Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep777 | Thyroid | ECE2021

Prognostic factors and therapeutic strategy for patients with bone metastases from differentiated thyroid carcinoma

Gherissi Wiem , Hamza Fatma , Charfi Hana , Jardak Issam , Maaloul Mohamed , Kallel Faouzi , Amouri Wissam , Charfeddine Salma , Chtourou Khalil , Guermazi Fadhel

Thyroid differentiated carcinomas are of good prognosis except in case of metastatic dissemination. These distant metastasis, especially the bone one, are a major cause of altered quality of life and death. This study concerns a cohort of 21 patients treated from 1995 to 2011.The aim of our work is to study the characteristics of patients who had bone metastases in association with thyroid cancer to determine their prognostic factors. 18 of our patients were ...

ea0073ep74 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Epidemiological aspects of differentiated thyroid carcinoma metastases

Charfi Hana , Fatma Hamza , Bechir Khrouf , Issam Jardak , Mohamed Maaloul , Faouzi Kallel , Wissam Amouri , Salma Charfeddine , Khalil Chtourou , Fadhel Guermazi

IntroductionDifferentiated thyroid cancer (DTC) is the most common thyroid cancer with a relatively high survival rate. Distant metastasis (DM) is not a frequent event in DTC but has an adverse impact on mortality of patients.PurposeThe aim of this study was to determine the most frequent metastases and their prognosis after adequate treatment.MethodsA retrospecti...

ea0073ep206 | Thyroid | ECE2021

The impact of clinicopathological characteristics of differentiated thyroid cancer on free-disease survival

Charfi Hana , Fatma Hamza , Wiem Gherissi , Issam Jardak , Mohamed Maaloul , Faouzi Kallel , Wissam Amouri , Salma Charfeddine , Khalil Chtourou , Fadhel Guermazi

IntroductionDifferentiated thyroid cancer (DTC) is a rare disease (1%), and usually has good prognosis if well treated. However, the percentage of mortality due to this cancer is about 0.5%. Moreover, 5 to 27%of patients treated for DTC suffer from regional recurrence. Therefore, many research tried to identify predective factors for the survival, relapse and progression of this cancer.PurposeThe aim of our s...

ea0090ep202 | Calcium and Bone | ECE2023

Gayet Wernicke’s encephalopathy: An exceptional complication of primary hyperparathyroidism

Elleuch Mouna , Soomauroo Siddiqa , Salah Dhouha Ben , Missaoui Abdel Mouhaymen , Maalej Souhir , Charfi Nadia , Hamza Fatma , Moalla Khadijah , Mnif Mouna , Mnif Fatma , Majdoub Nabila Rekik , Dammak Mariem , Guermazi Fadhel , Kacem Faten Hadj , Abid Mohamed

Introduction: Gayet Wernicke’s encephalopathy (GWE) is a severe encephalopathy secondary to acute thiamine (vitamin B1) deficiency which may lead to severe sequelae or death if the diagnosis is delayed. We report the first case in the literature of an association between GWE and primary hyperparathyroidism (PHP) in a man.Observation: He was a 57 years old man, with a personal history of hypertension and primary infertility, who presented with incoer...

ea0090ep640 | Endocrine-related Cancer | ECE2023

Parathyroid cancer and of primary hyperparathyroidism

Elleuch Mouna , Souhir Maalej , Ghamgui Wissal , Ben Salah Dhoha , Souleima Trigui , Charfi Nadia , Mnif Mouna , Mnif Fatma , Rekik Majdoub Nabila , Hamza Fatma , Guermazi Fadhel , Kacem Akid Faten Haj , Abid Mohamed

Parathyroid cancer is a rare cause of primary hyperparathyroidism (PPH). The objective of this work is to discuss clinical and therapeutic specificities of these tumors.Case n°151-year-old woman from a consanguineous marriage, with a family history of recurrent renal lithiasis, neoplasia, and a personal history of breast neoplasia and uterine fibroid, consulted for abdominal pain, vomiting and weight loss. The diagnosis of pri...